524636 — Oxygenta Pharmaceutical Share Price
Last trade - 00:00- IN₹1.13bn
- IN₹1.70bn
- IN₹396.42m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.22 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -33.71% | ||
| Return on Equity | n/a | ||
| Operating Margin | -25.08% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 137.16 | 520.27 | 605.25 | 309.87 | 396.42 | n/a | n/a | 14.09% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Oxygenta Pharmaceutical Limited is an India-based company, which is primarily engaged in the manufacturing of bulk drugs and active pharmaceutical ingredients (API). The Company is also engaged in the business of manufacturing all classes and kinds of drugs, including pharmaceutical preparation, and organic fine chemicals. The Company has its manufacturing facilities situated at Survey no. 252/1, Aroor Village, Sadasivapet Mandal, Sangareddy District, Telangana State.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- November 27th, 1990
- Public Since
- July 25th, 1994
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 35,483,500
- Address
- 170/C, HYDERABAD, 500032
- Web
- http://oxygentapharma.com
- Phone
- +91 4023543690
- Auditors
- Gowri Shankar & Associates
Upcoming Events for 524636
Similar to 524636
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
Ambalal Sarabhai Enterprises
Bombay Stock Exchange
FAQ
As of Today at 16:34 UTC, shares in Oxygenta Pharmaceutical are trading at IN₹35.99. This share price information is delayed by 15 minutes.
Shares in Oxygenta Pharmaceutical last closed at IN₹35.99 and the price had moved by -10.14% over the past 365 days. In terms of relative price strength the Oxygenta Pharmaceutical share price has underperformed the S&P BSE 100 Index by -31.34% over the past year.
There is no consensus recommendation for this security.
Oxygenta Pharmaceutical does not currently pay a dividend.
Oxygenta Pharmaceutical does not currently pay a dividend.
Oxygenta Pharmaceutical does not currently pay a dividend.
To buy shares in Oxygenta Pharmaceutical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹35.99, shares in Oxygenta Pharmaceutical had a market capitalisation of IN₹1.28bn.
Here are the trading details for Oxygenta Pharmaceutical:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 524636
Based on an overall assessment of its quality, value and momentum Oxygenta Pharmaceutical is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Oxygenta Pharmaceutical. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +0.19%.
As of the last closing price of IN₹35.99, shares in Oxygenta Pharmaceutical were trading +6.64% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Oxygenta Pharmaceutical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹35.99.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Oxygenta Pharmaceutical's directors